2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Improving intravenous-to-oral antibiotic switch in children: a team-based audit and implementation approach

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Children in hospital are frequently prescribed intravenous antibiotics for longer than needed. Programmes to optimise timely intravenous-to-oral antibiotic switch may limit excessive in-hospital antibiotic use, minimise complications of intravenous therapy and allow children to go home faster. Here, we describe a quality improvement approach to implement a guideline, with team-based education, audit and feedback, for timely, safe switch from intravenous-to-oral antibiotics in hospitalised children. Eligibility for switch was based on evidence-based guidelines and supported by education and feedback. The project was conducted over 12 months in a tertiary paediatric hospital. Primary outcomes assessed were the proportion of eligible children admitted under paediatric and surgical teams switched within 24 hours, and switch timing prior to and after guideline launch. Secondary outcomes were hospital length of stay, recommencement of intravenous therapy or readmission. The percentage of children switched within 24 hours of eligibility significantly increased from 32/50 (64%) at baseline to 203/249 (82%) post-implementation (p=0.006). The median time to switch fell from 15 hours 42 min to 4 hours 20 min (p=0.0006). In addition, there was a 14-hour median reduction in hospital length of stay (p=0.008). Readmission to hospital and recommencement of intravenous therapy did not significantly change postimplementation. This education, audit and feedback approach improved timely intravenous-to-oral switch in children and also allowed for more timely discharge from hospital. The study demonstrates proof of concept for this implementation with a methodology that can be readily adapted to other paediatric inpatient settings.

          Related collections

          Most cited references12

          • Record: found
          • Abstract: not found
          • Article: not found

          A primer on leading the improvement of systems

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines.

            Few studies are available to inform duration of intravenous antibiotics for children and when it is safe and appropriate to switch to oral antibiotics. We have systematically reviewed antibiotic duration and timing of intravenous to oral switch for 36 paediatric infectious diseases and developed evidence-graded recommendations on the basis of the review, guidelines, and expert consensus. We searched databases and obtained information from references identified and relevant guidelines. All eligible studies were assessed for quality. 4090 articles were identified and 170 studies were included. Evidence relating antibiotic duration to outcomes in children for some infections was supported by meta-analyses or randomised controlled trials; in other infections data were from retrospective series only. Criteria for intravenous to oral switch commonly included defervescence and clinical improvement with or without improvement in laboratory markers. Evidence suggests that intravenous to oral switch can occur earlier than previously recommended for some infections. We have synthesised recommendations for antibiotic duration and intravenous to oral switch to support clinical decision making and prospective research.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Short- versus long-term antimicrobial treatment for acute hematogenous osteomyelitis of childhood: prospective, randomized trial on 131 culture-positive cases.

              Considerable uncertainty exists on the optimal duration of antimicrobials for acute hematogenous osteomyelitis (AHOM) in children. Often they are administered for 1 to 2 months, the first 1 to 2 weeks intravenously, and decompressive surgery is usually added. No prospective, randomized, sufficiently powered comparative trial has been available. Children aged 3 months to 15 years with culture-positive AHOM were randomly assigned to receive clindamycin or a first-generation cephalosporin for 20 or 30 days, including an intravenous phase for the first 2 to 4 days. Surgery was kept at minimum. Illness was monitored with preset criteria. Antimicrobial was discontinued once most signs had subsided and serum C-reactive protein decreased ≤20 mg/L. The primary end point was full recovery without need for further antimicrobial therapy because of an osteoarticular indication during the 12 months after the primary therapy. Of the 131 cases, 18% also involved the adjacent joint. Staphylococcus aureus caused 89% of cases, and all strains were methicillin susceptible. The median duration of treatment was 20 days for 67 children, and 30 days for 64 children. Most children underwent only the diagnostic percutaneous aspiration or drilling, and 24% had no surgery. Except for 1 mild sequela in both treatment groups, all patients recovered entirely. Most cases of childhood AHOM can be treated for 20 days, including a short period intravenously, with large doses of a well-absorbed antimicrobial such as clindamycin or a first-generation cephalosporin, provided the clinical response is good and C-reactive protein normalizes within 7 to 10 days. Extensive surgery is rarely needed.
                Bookmark

                Author and article information

                Journal
                BMJ Open Qual
                BMJ Open Qual
                bmjqir
                bmjoq
                BMJ Open Quality
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                2399-6641
                2021
                17 March 2021
                : 10
                : 1
                : e001120
                Affiliations
                [1 ]departmentDepartment of Immunology and Infectious Diseases , Sydney Children's Hospital Randwick , Sydney, New South Wales, Australia
                [2 ]departmentNHMRC National Centre for Infections in Cancer, Sir Peter MacCallum Department of Oncology, University of Melbourne , Peter MacCallum Cancer Institute , Melbourne, Victoria, Australia
                [3 ]departmentSchool of Women's and Children's Health , University of New South Wales , Sydney, New South Wales, Australia
                [4 ]departmentMedication Safety , Clinical Excellence Commission , Sydney, New South Wales, Australia
                [5 ]departmentPharmacy Department , Sydney Children's Hospital Randwick , Sydney, New South Wales, Australia
                [6 ]departmentDepartment of General Paediatrics , Sydney Children's Hospital Randwick , Sydney, New South Wales, Australia
                [7 ]departmentDepartment of Paediatric Surgery , Sydney Children's Hospital Randwick , Sydney, New South Wales, Australia
                [8 ]departmentChild Health Department , Sultan Qaboos University , Muscat, Oman
                [9 ]departmentDepartment of Nursing , Sydney Children's Hospital Randwick , Sydney, New South Wales, Australia
                [10 ]departmentInfectious Diseases and Hospital in the Home Departments , The Royal Children's Hospital , Melbourne, Victoria, Australia
                [11 ]departmentClinical Paediatrics , Murdoch Childrens Research Institute , Melbourne, Victoria, Australia
                [12 ]departmentNational Centre for Antimicrobial Stewardship , The Peter Doherty Institute for Infection and Immunity , Melbourne, Victoria, Australia
                Author notes
                [Correspondence to ] Dr Brendan Joseph McMullan; b.mcmullan@ 123456unsw.edu.au
                Author information
                http://orcid.org/0000-0001-5144-3416
                Article
                bmjoq-2020-001120
                10.1136/bmjoq-2020-001120
                7978100
                33731484
                a92390cd-1c3e-416b-8b54-eae20c9779d2
                © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

                This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:  http://creativecommons.org/licenses/by-nc/4.0/.

                History
                : 20 July 2020
                : 14 February 2021
                : 28 February 2021
                Categories
                Quality Improvement Report
                1506
                Custom metadata
                unlocked

                antibiotic management,audit and feedback,healthcare quality improvement,teamwork,paediatrics

                Comments

                Comment on this article